RealTalk MS Episode 26: Stephanie Buxhoeveden Is An MS Nurse Who Also Happens To Have MS

Apr 3, 2018

 

My podcast guest Stephanie Buxhoeveden was diagnosed with MS when she was 25 years old, working as a neurosurgical ICU nurse. Today, Stephanie is a board-certified Multiple Sclerosis Nurse, she is a Nurse Practitioner and she is the Co-Director of the MS Comprehensive Care Center where she has also been a patient.

 

 

Stephanie will share some of her experiences and observations from the dual perspective of someone who is a medical specialist who treats patients with MS, and also someone who lives with MS.

 

We're also talking about the results of the very first clinical trial to demonstrate a slowing in the progression of disability in secondary progressive MS. We'll tell you about a new Canadian study that shows a clear connection between depression and physical disability in MS. And we'll talk about the kind of information that California's new prescription drug price transparency bill is revealing.

____________

 :18     MS Awareness -- It's A 12-Month Campaign

3:01    New Drug Slows Disability Progression in Secondary Progressive MS

4:09    Study Shows Depression Impacts MS Physical Disability

6:42    Drug Price Transparency Law in California Begins to Reveal Real Information

8:49    Interview with Stephanie Buxhoeveden

___________

LINKS
If your podcast app doesn’t show these links, you’ll find them in the show notes at www.RealTalkMS.com

Articles & Videos by Stephanie Buxhoeveden

GPS For Your MS: Initiating Your Wellness Journey

Emergency Preparedness

Facing the Emotional Symptoms of MS Together

TedX Talk: Thriving In The Face of Adversity

MS Path 2 Care

___________

For more RealTalk MS, follow us on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 26
Guests: Stephanie Buxhoeveden, MSCN, FN-BC, MS Activist
Hosted By: Jon Strum

Tags: MS, multiple sclerosis, Stephanie Buxhoeveden, Siponimod, MS and depression, MS prescription drug prices, prescription drug price transparency, MS podcast, RealTalk MS